Skip to main content
OpenTrials

Clinical trial condition

Intrahepatic Cholangiocarcinoma

Explore clinical trials studying Intrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

72 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Intrahepatic Cholangiocarcinoma trial results

Completed

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

NCT03230318

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Completed

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

NCT03849469

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • Koman Family Outpatient Pavilion La Jolla, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
View all 28 locations
View Trial Details
Completed

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

NCT02273739

Conditions
Adenocarcinoma, Angioimmunoblastic T-cell Lymphoma, Carcinoma, +22 more
Locations
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Miami, Florida, United States
  • Baltimore, Maryland, United States
View Trial Details
Completed

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma

NCT01938729

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States
View Trial Details

Related conditions